The number of CXCR3+ T cells is increased in the blood of RRMS, and they accumulate in perivascular infiltrates in active MS lesions [30,31], while SCYB10 (IP-10) and SCYB9 (MIG) are detected in the cerebrospinal fluid (CSF) of RRMS at acute relapse and expressed in reactive astrocytes in active MS lesions [31,32]. Here, CXCL10 is linked to myeloid sarcoma.